Photo by Pharmacy Images on Unsplash
Health Insurance Coverage Expanded for Long Covid Medications
Long Covid patients in Germany will soon benefit from statutory health insurance coverage for four specific medications, which were previously paid for out-of-pocket by those affected. The Gemeinsame Bundesausschuss (G-BA), the federal joint committee responsible for deciding on health insurance reimbursements, has authorized reimbursement for these medicines, despite none being officially approved specifically for Long Covid treatment. This marks a significant step toward easing the financial burden on patients struggling with persistent symptoms following COVID-19 infection [Source 1].
Long Covid refers to a range of symptoms that persist or newly emerge more than four weeks after the initial SARS-CoV-2 infection, with Post-Covid syndrome describing complaints lasting beyond twelve weeks. These symptoms include severe fatigue, pain, and other debilitating effects that have occasionally led to conditions like ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) [Source 1][Source 3].
Approved Medications for Long Covid on Insurance
The four drugs now reimbursable for Long Covid patients in Germany include:
- Agomelatin: An antidepressant aimed at alleviating fatigue symptoms common among Long Covid sufferers.
- Ivabradine: Originally used for heart conditions; it helps treat Postural Orthostatic Tachycardia Syndrome (POTS), which affects about one in three Long Covid patients.
- Metformin: Primarily a diabetes medication, it is prescribed off-label to overweight patients immediately after acute COVID-19 infection to potentially reduce Long Covid risk.
- Vitamin C (high-dose): Used to support overall recovery and reduce fatigue, though specifics about dosing and indications vary [Source 1][Source 3][Source 4].
This Off-label use, whereby drugs approved for other illnesses are applied to Long Covid, reflects the ongoing urgent need for effective therapies, as confirmed by G-BA chairman Josef Hecken [Source 1]. The recommendation still awaits final approval from the Federal Ministry of Health, which experts expect to be granted [Source 4].
Implications for Expats, International Students, and Foreign Workers in Germany
Expats and foreigners in Germany who are covered by statutory health insurance will now have improved access to essential medications for Long Covid without incurring considerable personal expenses. Previously, many had to pay for these prescription drugs themselves, creating financial barriers to treatment. With the new coverage, patients diagnosed with Long Covid should consult their healthcare providers about prescriptions for these medicines and verify insurance reimbursement eligibility.
It is important for expats to ensure they are registered with one of Germany’s public health insurers, as this benefit applies within the statutory system. Those relying on private insurance should check with their providers regarding coverage policies for off-label Long Covid treatments. Early treatment, especially for high-risk groups such as overweight patients, may involve prescriptions like Metformin shortly after infection.
For international students and workers, this development reduces uncertainty around treatment costs and provides clearer avenues for managing persistent post-COVID symptoms. It may be advisable to keep medical documentation organized and immediately seek medical advice if Long Covid symptoms develop, to benefit from the coverage and reduce long-term health impacts [Source 1][Source 7][Source 8].
For further details, the original report by Tagesschau provides comprehensive information: Long Covid: Krankenkassen übernehmen bald einzelne Medikamente [Source 1].
